Find a Genetics Study in your area

To find out more about current Genetics studies you can view a list of studies on the NIHR Clinical Research Network Portfolio Database 

Working with the Life Sciences

The NIHR Clinical Research Network Cancer has been enormously successful in integrating clinical research into NHS clinical service provision, and both developing and delivering a large practice changing portfolio of clinical trials.

View our Genetics specialty profile to find out more.

Our Studies



The Genetics Specialty supports the delivery and promotion of clinical research studies in a wide range of areas, including:

  • Rare diseases
  • Causes and prevention of birth defects
  • Common disorders such as familial cancer, and
  • Genetic approaches to their treatment and prevention

You can find out more about Genetics studies in your area through the UK Clinical Trials Gateway.


Personalised medicine for Asthma ConTrol (PACT) 

In the UK, asthma affects around five million people. A child is admitted to hospital every 18 minutes due to their asthma. The Genetics Specialty is currently supporting The Personalised medicine for Asthma ConTrol (PACT) study led by Professor Somnath Mukhopadhyay,  Brighton and Sussex Medical School, and the Royal Alexandra Children’s Hospital. This study is investigating whether prescribing medication according to a child’s genetic makeup could lead to better control of a their asthma. Find out more about this study.


The Deciphering Developmental Disorders (DDD) Study 

Every year, thousands of babies are born in the UK who do not develop normally because of errors in their genetic makeup. Currently, diagnosis is restricted to a small minority; upto half of children with severe developmental disorders of probable genetic origin remain without a diagnosis. The aim of the Deciphering Developmental Disorders Study (DDD) is to determine if new high-throughput genetic technologies can determine the cause of developmental disorders, and to facilitate the use of these technologies in the NHS. Analysis is ongoing, but to date the team have achieve a diagnostic rate of ~35% in patients where previous genetic investigations had failed to identify a diagnosis.  So far, more than 30 new developmental disorder genes have been identified as a result of this study.

Read more about the DDD study.